ChemoCentryx, Inc. Convertible Debt, Fair Value Disclosures
ChemoCentryx, Inc. had Convertible Debt, Fair Value Disclosures of $10.50 million as of 2011-12-31, per its 10-Q filed 2013-05-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:ConvertibleDebtFairValueDisclosures · last filed 2013-05-14
- 2011-12-31: Convertible Debt, Fair Value Disclosures $10.50M.
| Period end | Convertible Debt, Fair Value Disclosures |
|---|---|
| 2011-12-31 | $10.50M 10-Q · filed 2013-05-14 |